Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 354

1.

Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Hosing C, Munsell M, Yazji S, Andersson B, Couriel D, de Lima M, Donato M, Gajewski J, Giralt S, Körbling M, Martin T, Ueno NT, Champlin RE, Khouri IF.

Ann Oncol. 2002 Mar;13(3):450-9.

PMID:
11996478
[PubMed - indexed for MEDLINE]
Free Article
2.

Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies.

Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J, Clark T, Foran JM, Salam A, Lister TA, Rohatiner AZ.

J Clin Oncol. 2000 Mar;18(5):947-55.

PMID:
10694543
[PubMed - indexed for MEDLINE]
3.

Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.

Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S.

J Clin Oncol. 2003 Mar 1;21(5):897-906. Review.

PMID:
12610191
[PubMed - indexed for MEDLINE]
4.
5.

Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.

Nademanee A, Molina A, Dagis A, Snyder DS, O'Donnell MR, Parker P, Stein A, Smith E, Planas I, Kashyap A, Spielberger R, Fung H, Krishnan A, Bhatia R, Wong KK, Somlo G, Margolin K, Chow W, Sniecinski I, Vora N, Slovak M, Niland JC, Forman SJ.

Clin Lymphoma. 2000 Jun;1(1):46-54.

PMID:
11707813
[PubMed - indexed for MEDLINE]
6.

Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors.

Krishnan A, Bhatia S, Slovak ML, Arber DA, Niland JC, Nademanee A, Fung H, Bhatia R, Kashyap A, Molina A, O'Donnell MR, Parker PA, Sniecinski I, Snyder DS, Spielberger R, Stein A, Forman SJ.

Blood. 2000 Mar 1;95(5):1588-93.

PMID:
10688812
[PubMed - indexed for MEDLINE]
Free Article
7.

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.

Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, et al.

J Clin Oncol. 1994 Dec;12(12):2527-34.

PMID:
7989926
[PubMed - indexed for MEDLINE]
8.

Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.

Howe R, Micallef IN, Inwards DJ, Ansell SM, Dewald GW, Dispenzieri A, Gastineau DA, Gertz MA, Geyer SM, Hanson CA, Lacy MQ, Tefferi A, Litzow MR.

Bone Marrow Transplant. 2003 Aug;32(3):317-24.

PMID:
12858205
[PubMed - indexed for MEDLINE]
9.

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.

Sacchi S, Marcheselli L, Bari A, Marcheselli R, Pozzi S, Luminari S, Lombardo M, Buda G, Lazzaro A, Gobbi PG, Stelitano C, Morabito F, Quarta G, Brugiatelli M.

Haematologica. 2008 Mar;93(3):398-404. doi: 10.3324/haematol.12120. Epub 2008 Feb 11.

PMID:
18268277
[PubMed - indexed for MEDLINE]
Free Article
10.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ.

Blood. 2003 Mar 1;101(5):2015-23. Epub 2002 Oct 10.

PMID:
12393427
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma.

Berglund A, Enblad G, Carlson K, Glimelius B, Hagberg H.

Eur J Haematol. 2000 Jul;65(1):17-22.

PMID:
10914935
[PubMed - indexed for MEDLINE]
13.

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, et al.

J Clin Oncol. 1994 Dec;12(12):2535-42.

PMID:
7989927
[PubMed - indexed for MEDLINE]
14.

A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.

Jang GD, Kim SW, Suh CW, Kim EK, Bahng HS, Jeong YH, Park IG, Kim WK, Kim SH, Suh EJ, Park CJ, Ji HS, Lee JS.

J Korean Med Sci. 2002 Aug;17(4):555-9.

PMID:
12172056
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.

Forrest DL, Hogge DE, Nevill TJ, Nantel SH, Barnett MJ, Shepherd JD, Sutherland HJ, Toze CL, Smith CA, Lavoie JC, Song KW, Voss NJ, Gascoyne RD, Connors JM.

J Clin Oncol. 2005 Nov 1;23(31):7994-8002. Epub 2005 Oct 3.

PMID:
16204014
[PubMed - indexed for MEDLINE]
16.

High dose chemotherapy and autologous stem cell transplantation for poor risk and recurrent non-Hodgkin's lymphoma: a single-center experience of 50 patients.

Shim BY, Lee MA, Byun JH, Roh SY, Song CW, Park JN, Lee JW, Min WS, Hong YS, Kim CC.

Korean J Intern Med. 2004 Jun;19(2):114-20.

PMID:
15366643
[PubMed - indexed for MEDLINE]
Free Article
17.

Therapy-related myelodysplasia and/or acute myeloid leukaemia after autologous haematopoietic progenitor cell transplantation in a prospective single centre cohort of 221 patients.

Beauchamp-Nicoud A, Feneux D, Bayle C, Bernheim A, Léonard C, Koscielny S, Tchernia G, Bourhis JH.

Br J Haematol. 2003 Jul;122(1):109-17.

PMID:
12823352
[PubMed - indexed for MEDLINE]
18.

Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.

Bennett JM, Kaminski MS, Leonard JP, Vose JM, Zelenetz AD, Knox SJ, Horning S, Press OW, Radford JA, Kroll SM, Capizzi RL.

Blood. 2005 Jun 15;105(12):4576-82. Epub 2005 Feb 24.

PMID:
15731177
[PubMed - indexed for MEDLINE]
Free Article
19.

Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.

Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E, Bolwell B.

J Clin Oncol. 2006 Aug 1;24(22):3604-10.

PMID:
16877727
[PubMed - indexed for MEDLINE]
20.

Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.

Kobos R, Steinherz PG, Kernan NA, Prockop SE, Scaradavou A, Small TN, Shukla N, Khalaf R, O'Reilly RJ, Boulad F.

Biol Blood Marrow Transplant. 2012 Mar;18(3):473-80. doi: 10.1016/j.bbmt.2011.11.009. Epub 2011 Nov 10.

PMID:
22079789
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk